Pitfalls in prenatal diagnosis of 21-hydroxylase deficiency by amniotic fluid steroid analysis? A six years experience in 102 pregnancies at risk.
D019326:17-alpha-Hydroxyprogesterone; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis*; D000653:Amniotic Fluid / Q000032:analysis*; D000735:Androstenedione / Q000032:analysis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D005817:Genetic Counseling; D006650:Histocompatibility Testing; D006801:Humans; D006908:Hydroxyprogesterones / Q000032:analysis; D007231:Infant, Newborn; D007621:Karyotyping; D008297:Male; D010375:Pedigree; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012306:Risk; D013250:Steroid Hydroxylases / Q000172:deficiency*; D013739:Testosterone / Q000032:analysis
D006908:Hydroxyprogesterones; D013739:Testosterone; D000735:Androstenedione; D019326:17-alpha-Hydroxyprogesterone; D013250:Steroid Hydroxylases